SREBP-‐1c, ChREBPy LXR…
43
94.
Chen, G., Liang, G., Ou, J. y col. 2004. Central role for liver X receptor in insulin-‐mediated
activation of Srebp-‐1c transcription and stimulation of fatty acid synthesis in liver. Proc
Natl AcadSciUSA101, 11245-‐11250.
95.
Ye, J., DeBose-‐Boyd, R.A., 2011. Regulation of cholesterol and fatty acid synthesis. Cold
SpringHarbPerspectBiol 3. pii: a0047
96.
Bobard, A., Hainault, I., Ferré, P. y col. 2005. Differential regulation of sterol regulatory
element-‐binding protein 1c transcriptional activity by insulin and liver X receptor during
liverdevelopment. JBiol Chem280, 199-‐206.
97.
Horton, J.D., Bashmakov, Y., Shimomura, I., Shimano, H., 1998. Regulation of sterol
regulatoryelement bindingproteins in liversof fastedandrefedmice. ProcNatl AcadSciU
SA95, 5987-‐599217.
98.
Hasty, A.H., Shimano, H., Yahagi, N., Amemiya-‐Kudo, M. y col. 2000. Sterol regulatory
element-‐binding protein-‐1 is regulated by glucose at the transcriptional level. J Biol Chem
275, 31069-‐31077.
99.
Dentin, R., Pégorier, J.P., Benhamed, F. y col. 2004. Hepatic glucokinase is required for the
synergistic action of ChREBP and SREBP-‐1c on glycolytic and lipogenic gene expression. J
Biol Chem279, 20314-‐20326.
100.
Liang, G., Yang, J., Horton, J.D. y col. 2002. Diminished hepatic response to
fasting/refeeding and liver X receptor agonists inmice with selective deficiency of sterol
regulatoryelement-‐bindingprotein-‐1c. JBiol Chem277, 9520-‐9528.
101.
Nagai, Y., Yonemitsu, S., Erion, D.M. y col. 2009. The role of peroxisome
proliferator-‐activated receptor gamma coactivator-‐1 beta in the pathogenesis of fructose-‐
induced insulinresistance. CellMetab9, 252-‐264.
102.
Lee, J.N., Zhang, X., Feramisco, J.D. y col. 2008. Unsaturated fatty acids inhibit
proteasomal degradation of Insig-‐1 at a postubiquitination step. J Biol Chem283, 33772-‐
33783.
103.
Kammoun, H.L., Chabanon, H., Hainault, I. y col. 2009. GRP78 expression inhibits
insulinandERstress-‐inducedSREBP-‐1c activationand reduces hepatic steatosis inmice. J
Clin Invest 119, 1201-‐1215.
104.
Inoue, J., Ito, Y., Shimada, S. y col. 2011. Glutamine stimulates the gene expression
and processing of sterol regulatory element binding proteins, thereby increasing the
expressionof their target genes. FEBS J 278, 2739-‐2750.
105.
Xia, M., Liu, Y., Guo, H. y col. 2013. Retinol binding protein 4 stimulates hepatic
sterol regulatory element-‐binding protein 1 and increases lipogenesis through the
peroxisome proliferator-‐activated receptor-‐γ coactivator 1β-‐dependent pathway.
Hepatology58, 564-‐575.
106.
Zhang, Y., Lei, T., Huang, J.F. y col. 2011. The linkbetween fibroblast growth factor
21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes.
Mol Cell Endocrinol 342, 41-‐47.
107.
Ruderman, N.B., Xu, X.J., Nelson, L. y col. 2010. AMPK and SIRT1: a long-‐standing
partnership?AmJ Physiol EndocrinolMetab298, E751-‐760.
108.
Bécard, D., Hainault, I., Azzout-‐Marniche, D. y col. 2001. Adenovirus-‐mediated
overexpression of sterol regulatory element binding protein-‐1c mimics insulin effects on
hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 50, 2425-‐
2430.
109.
Lemoine, M., Barbu, V., Girard, P.M. y col. 2006. Altered hepatic expression of
SREBP-‐1 and PPARgamma is associated with liver injury in insulin-‐resistant
lipodystrophicHIV-‐infectedpatients. AIDS20, 387-‐395.
110.
Eberlé, D., Clément, K., Meyre, D. y col. 2004. SREBF-‐1 gene polymorphisms are
associatedwithobesityand type2diabetes inFrenchobeseanddiabetic cohorts. Diabetes
53, 2153-‐2157.
111.
Biddinger, S.B., Almind, K., Miyazaki, M. y col. 2005. Effects of diet and genetic
background on sterol regulatory element-‐binding protein-‐1c, stearoyl-‐CoA desaturase 1,
and thedevelopment of themetabolic syndrome. Diabetes54, 1314-‐1323.
112.
Teran-‐Garcia, M., Adamson, A.W., Yu, G. y col. 2007. Polyunsaturated fatty acid
suppression of fatty acid synthase (FASN): evidence for dietary modulation of NF-‐Y
binding to theFasnpromoterbySREBP-‐1c. BiochemJ 402, 591-‐600.
113.
Leavens, K.F., Easton, R.M., Shulman, G.I. y col. 2009. Akt2 is required for hepatic
lipidaccumulation inmodelsof insulinresistance. CellMetab10, 405-‐418.
